Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79216832 | 7921683 | 2 | F | 20160516 | 20160520 | 20110429 | 20160829 | PER | US-ASTRAZENECA-2010SE49039 | ASTRAZENECA | 23269.00 | DY | F | Y | 68.90000 | KG | 20160829 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79216832 | 7921683 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | |||||||||||
| 79216832 | 7921683 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG 60 INHALATIONS | U | U | 0 | ||||||||
| 79216832 | 7921683 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG 60 INHALATIONS | U | U | 0 | ||||||||
| 79216832 | 7921683 | 4 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 0 | 40 | MG | QD | |||||||
| 79216832 | 7921683 | 5 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | U | U | 0 | 100 | MG | QD | ||||||
| 79216832 | 7921683 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 79216832 | 7921683 | 7 | C | TOPAMAX | TOPIRAMATE | 1 | Oral | 0 | 100 | MG | BID | ||||||||
| 79216832 | 7921683 | 8 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 0 | 1 | MG | QD | ||||||||
| 79216832 | 7921683 | 9 | C | TEMAZEPAM. | TEMAZEPAM | 1 | Oral | 0 | 15 | MG | QD | ||||||||
| 79216832 | 7921683 | 10 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Oral | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 79216832 | 7921683 | 2 | Asthma |
| 79216832 | 7921683 | 3 | Bronchitis chronic |
| 79216832 | 7921683 | 5 | Post-traumatic stress disorder |
| 79216832 | 7921683 | 6 | Blood cholesterol |
| 79216832 | 7921683 | 7 | Headache |
| 79216832 | 7921683 | 8 | Restless legs syndrome |
| 79216832 | 7921683 | 9 | Sleep disorder |
| 79216832 | 7921683 | 10 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 79216832 | 7921683 | Chest pain | |
| 79216832 | 7921683 | Drug dose omission | |
| 79216832 | 7921683 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 79216832 | 7921683 | 2 | 2012 | 0 | ||
| 79216832 | 7921683 | 3 | 2012 | 0 | ||
| 79216832 | 7921683 | 4 | 2014 | 0 | ||
| 79216832 | 7921683 | 5 | 2015 | 0 | ||
| 79216832 | 7921683 | 6 | 2011 | 0 | ||
| 79216832 | 7921683 | 7 | 2013 | 0 | ||
| 79216832 | 7921683 | 8 | 2011 | 0 | ||
| 79216832 | 7921683 | 9 | 2014 | 0 | ||
| 79216832 | 7921683 | 10 | 2014 | 0 |